Pardis Sabeti

Title: Pardis Sabeti: Innovator in Antiviral Therapies

Introduction

Pardis Sabeti is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of immunology and antiviral therapies. With a total of 10 patents, her work focuses on innovative solutions to combat viral infections, particularly in the context of emerging pathogens.

Latest Patents

One of her latest patents is titled "Immunogenic compositions and use thereof." This invention involves immunogenic compositions comprising one or more polypeptides capable of binding to Major Histocompatibility Complex (MHC) class I, derived from proteins of SARS-COV-2. The patent also includes methods for treating and preventing diseases using these immunogenic compositions. Another notable patent is the "CRISPR system based antiviral therapy." This invention presents a new approach for highly multiplexed, programmable antiviral therapies that directly target viral RNA. It can be adapted to target novel viruses or emerging outbreak pathogens, offering a flexible solution to combat viral resistance.

Career Highlights

Pardis Sabeti has worked at prestigious institutions such as Harvard College and The Broad Institute, Inc. Her research has been pivotal in advancing our understanding of viral infections and developing effective therapeutic strategies.

Collaborations

Some of her notable coworkers include Andres Colubri and Hayden Metsky. Their collaborative efforts have contributed to the success of her innovative projects.

Conclusion

Pardis Sabeti's work exemplifies the intersection of innovation and public health. Her contributions to antiviral therapies and immunogenic compositions are vital in the ongoing fight against viral diseases.